Immediate Impact
18 standout
Citing Papers
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
New clinical trial design in precision medicine: discovery, development and direction
2024 Standout
Works of Loretta Sullivan being referenced
Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial
2022 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Loretta Sullivan | 97 | 146 | 6 | 105 | 4 | 230 | |
| A Charbit | 106 | 130 | 2 | 57 | 6 | 290 | |
| Leonard M. Holtegaard | 74 | 113 | 9 | 69 | 7 | 298 | |
| Maribel Mármol | 29 | 173 | 81 | 8 | 275 | ||
| April Fritz | 53 | 131 | 67 | 7 | 222 | ||
| Christina Zander | 90 | 163 | 156 | 4 | 267 | ||
| J. Morreau | 86 | 189 | 1 | 58 | 7 | 287 | |
| S G Taylor | 66 | 142 | 65 | 7 | 283 | ||
| Victoria Williams | 76 | 67 | 3 | 98 | 7 | 203 | |
| Farida Mesli | 54 | 114 | 1 | 73 | 5 | 228 | |
| J. Selleslags | 64 | 194 | 72 | 7 | 243 |
All Works
Loading papers...